Robin Goytia, MD
Adult Reconstructive Orthopaedic Surgery · Houston, TXNPI 1538284534
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $38,678 of the $45,743 with a category attached, or 84.6%. Medical Device Business Services, Inc. accounts for 91.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $23,032 and has fallen 77.0% since, to $5,293 in 2025.
Across 53 payments — averaging $863.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$42K
- Medinc Of Texas$2K
- Johnson & Johnson$1K
- Stryker$907
- Zimmer Biomet$79
- Medtronic$38
Across 20 payments — averaging $2450.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$29K
- Zimmer Biomet$20K
What the payments were for
- Consulting fees$38,67885%
- Travel & lodging$3,1067%
- Food & beverage$2,2895%
- Education$1,6704%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 30 | $41,940 |
| Medinc Of Texas | 1 | $1,670 |
| Johnson & Johnson(2 entities) | 10 | $1,109 |
| Stryker | 10 | $907 |
| Zimmer Biomet | 1 | $79 |
| Medtronic | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$45,743 in reported general payments places this provider in the 75th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 1,360 | $5,312 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 350 | $3,261 |
| Tranexamic Acid | 79 | $1,972 |
| Doxycycline Hyclate | 274 | $1,783 |
| Celecoxib | 115 | $1,335 |
| Tramadol Hcl | 384 | $1,001 |
| Methocarbamol | 162 | $600 |
| Diclofenac Sodium | 19 | $585 |
| Amoxicillin | 258 | $198 |
| Clindamycin Hcl | 65 | $157 |
| Ondansetron Hcl | 27 | $117 |
| Gabapentin | 16 | $77 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Houston
- Anay PatelHouston$191K
- Catherine CahillHouston$143K
- Cory CouchHouston$118K
- David MaldonadoHouston$65K
- Alexander MetoxenHouston$26K
- Nathan RogersHouston$20K
- Clark DormanHouston$15K
- David EdelsteinHouston$13K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.